Cortisol and Growth Hormone Secretion in Relation to Linear Growth: Patients with Still's Disease on Different Therapeutic Regimens

37Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Linear growth was studied in 20 children suffering from Still's disease on various treatment regimens, and their ability to secrete growth hormone and cortisol was investigated. Growth recovered on reducing daily corticosteroid therapy or on changing to an alternative regimen. Retardation of growth was not due to an absolute inability to secrete growth hormone. Basal plasma cortisol levels and the plasma cortisol response to hypoglycaemia were reduced in patients on daily steroid therapy, but patients on alternate-day prednisone did not differ significantly in this respect from those on non-steroid regimens. Those on alternate-day corticotrophin showed preservation of the circadian rhythm but a subnormal response to hypoglycaemia. © 1970, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Sturge, R. A., Beardwell, C., Hartog, M., Wright, D., & Ansell, B. M. (1970). Cortisol and Growth Hormone Secretion in Relation to Linear Growth: Patients with Still’s Disease on Different Therapeutic Regimens. British Medical Journal, 3(5722), 547–551. https://doi.org/10.1136/bmj.3.5722.547

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free